5-Fluoroorotic acid, min. 98%, for biochemistry, 1 g, glass packaging

N-(4-ethoxy-2-nitrophenyl)acetamide, 1g

N,N-Dimethyl-1-(4-vinylphenyl)methanamine, 97% mix TBC as stabilizer, 100mg

4-Fluoro-7-nitro-1H-indazole, 95.0%, 100mg

1-Benzyl-4-cyano-4-phenylpiperidine Hydrochloride>98.0%(HPLC)(T)25g

Methyl 4-((tert-butoxycarbonyl)amino)piperidine-4-carboxylate oxalate(2:1), 98+%, 10g

4-Oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate, 97%, 10mg

(4-(Cyclopentylcarbamoyl)-3-fluorophenyl)boronic acid, 95.0%, 100mg

(8-Benzyl-1,4-dioxa-8-aza-spiro[4.5]dec-6-yl)-methanol, 95.0%, 250mg

Ethyl 2-(2-Bromophenyl)acetate, 97.0%, 25g

N-(2-Methoxyethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 1g

2-Phenyl-1,6-naphthyridine-3-carboxylic acid, 95.0%, 100mg

Methyl 1-aminocyclopropanecarboxylate, 95.0%, 10g